Ethereum:
2,524.14
-48.3
-1.88%
|
Bitcoin:
105,527.98
1,753.78
1.69%
|
Monero:
343.51
8.4
2.52%
|
Ethereum:
2,524.14
-48.3
-1.88%
|
|
Bitcoin:
105,527.98
1,753.78
1.69%
|
|
Monero:
343.51
8.4
2.52%
|
|
News about Stock Market Trading
|
On Friday, May 16, 2025, U.S. stock markets opened strong, with major indices registering gains driven by robust performances in the healthcare and services sectors. The day reflected broad-based optimism on Wall Street, particularly following a solid trading session the day prior.
The SandP 500, climbing for a potential fifth consecutive day, was buoyed by healthcare stocks, which rose by 0.87%, and the services sector, gaining 0.83%. Encouraging signs of market stability were reflected across the board, as major indices maintained their upward trajectories amid positive economic reports.
In specific stocks, Occidental Petroleum Corporation showcased impressive revenue growth and announced a strategic partnersh...
|
Nasd100: 21,447
19.12
0.09%
|
|
|
Best Performing Industries |
Worst Performing Industries
|
|
Select Best and Worst performers from years before
|
Best Performing Stocks From The Best Performing (Biotechnology & Pharmaceuticals) Industry Today
ARMP
$2.37
$1.0200
75.56%
Today's
|
|
|
ARMP
$2.37
$1.0200
75.56%
Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc shares increased 75.56% today.
Armata Pharmaceuticals Inc operates on a research and development business model focused on discovering and developing bacteriophage-based therapies to combat antibiotic-resistant infections. They utilize their proprietary phage technology platform to create novel pharmaceutical products targeting various bacterial diseases.
|
ELEV
$0.34
$0.0575
20.35%
Today's
|
|
|
ELEV
$0.34
$0.0575
20.35%
Elevation Oncology inc
Elevation Oncology Inc shares improved 20.35% today.
Elevation Oncology Inc*s business model focuses on precision medicine and targeted therapies for rare and genomically defined cancers.
|
TIL
$16.9
$2.2700
15.52%
Today's
|
|
|
TIL
$16.9
$2.2700
15.52%
Instil Bio Inc
Instil Bio Inc stock increased 15.52% today.
Instil Bio Inc operates with a business model focusing on developing and commercializing innovative cell therapy products for the treatment of cancer. They aim to leverage advanced technologies and strategic partnerships to advance their pipeline and bring novel therapies to market.
|
NVAX
$7.74
$1.0100
15.01%
Today's
|
|
|
NVAX
$7.74
$1.0100
15.01%
Novavax inc
Novavax Inc shares went up 15.01% today.
Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market.
|
FATE
$1.22
$0.1500
14.02%
Today's
|
|
|
FATE
$1.22
$0.1500
14.02%
Fate Therapeutics Inc
Fate Therapeutics Inc shares improved 14.02% today.
Fate Therapeutics Inc*s business model revolves around the development and commercialization of innovative cell-based therapies to treat various diseases.
|
ENGN
$3.91
$0.4600
13.33%
Today's
|
|
|
ENGN
$3.91
$0.4600
13.33%
Engene Holdings Inc
Engene Holdings Inc stock improved 13.33% today.
|
SRZN
$8.03
$0.9300
13.10%
Today's
|
|
|
SRZN
$8.03
$0.9300
13.10%
Surrozen Inc
Surrozen Inc stock went up 13.10% today.
Surrozen Inc*s business model revolves around biotechnology and therapeutics, specifically focusing on regenerative medicine.
|
CRBU
$1.05
$0.1116
11.89%
Today's
|
|
|
CRBU
$1.05
$0.1116
11.89%
Caribou Biosciences Inc
Caribou Biosciences Inc shares improved 11.89% today.
Caribou Biosciences Inc is a biotechnology company that focuses on the development of gene editing technologies. Their business model involves licensing their proprietary CRISPR-Cas9 platform and collaborating with partners to advance research and therapeutic applications in various industries.
|
FENC
$7.65
$0.8100
11.84%
Today's
|
|
|
FENC
$7.65
$0.8100
11.84%
Fennec Pharmaceuticals inc
Fennec Pharmaceuticals Inc stock went up 11.84% today.
|
QNCX
$0.9493
$0.0993
11.68%
Today's
|
|
|
QNCX
$0.9493
$0.0993
11.68%
Quince Therapeutics Inc
Quince Therapeutics Inc shares went up 11.68% today.
|
CCCC
$1.54
$0.1600
11.59%
Today's
|
|
|
CCCC
$1.54
$0.1600
11.59%
C4 Therapeutics Inc
C4 Therapeutics Inc stock increased 11.59% today.
C4 Therapeutics Inc operates on a business model that focuses on developing novel therapies using their proprietary Degronimid? platform, designed to selectively target and degrade disease-causing proteins. This approach potentially offers a new avenue for treating various diseases by harnessing the body*s natural protein degradation machinery.
|
TECX
$23.41
$2.4200
11.53%
Today's
|
|
|
TECX
$23.41
$2.4200
11.53%
Tectonic Therapeutic Inc
Tectonic Therapeutic Inc stock increased 11.53% today.
|
SCLX
$4.695
$0.4850
11.52%
Today's
|
|
|
SCLX
$4.695
$0.4850
11.52%
Scilex Holding Company
Scilex Holding Company stock went up 11.52% today.
Scilex Holding Company operates as a pharmaceutical company focused on the development and commercialization of prescription drugs. Through its business model, it aims to identify and acquire assets that have the potential to address unmet medical needs and improve patient outcomes. The company primarily focuses on developing innovative, differentiated products in the therapeutic areas of pain management and neurology.
|
AUTL
$1.48
$0.1500
11.28%
Today's
|
|
|
AUTL
$1.48
$0.1500
11.28%
Autolus Therapeutics Plc
Autolus Therapeutics Plc stock increased 11.28% today.
Autolus Therapeutics Plc is a biopharmaceutical company that focuses on the development and commercialization of next-generation engineered T-cell therapies for the treatment of cancer. Their business model is centered around utilizing innovative technology and expertise to create and advance novel therapies aimed at improving patient outcomes in oncology.
|
FDMT
$3.8
$0.3600
10.47%
Today's
|
|
|
FDMT
$3.8
$0.3600
10.47%
4d Molecular Therapeutics Inc
4d Molecular Therapeutics Inc stock improved 10.47% today.
4D Molecular Therapeutics Inc operates with a business model focused on developing innovative gene therapy products to address serious genetic diseases. The company utilizes its proprietary technology platform to design and optimize viral vectors for targeted gene delivery. With a strong commitment to research and development, 4D Molecular Therapeutics collaborates with partners in academia, industry, and patient organizations to advance transformative treatments for patients in need.
|
IOVA
$1.83
$0.1700
10.24%
Today's
|
|
|
IOVA
$1.83
$0.1700
10.24%
Iovance Biotherapeutics inc
Iovance Biotherapeutics Inc stock improved 10.24% today.
Iovance Biotherapeutics Inc operates on a business model centered around developing and commercializing novel cancer immunotherapy treatments. The company focuses on utilizing its proprietary Tumor Infiltrating Lymphocyte (TIL) therapy, which involves collecting and expanding a patient*s own immune cells to target and kill cancer cells. Iovance primarily seeks to advance its TIL therapy candidates through clinical trials and collaborations while aiming to provide effective and personalized treatment options for cancer patients.
|
RGNX
$9.79
$0.9000
10.12%
Today's
|
|
|
RGNX
$9.79
$0.9000
10.12%
Regenxbio Inc
Regenxbio Inc shares increased 10.12% today.
Regenxbio Inc is a biotechnology company that focuses on the development and commercialization of gene therapy treatments for various diseases. Their business model revolves around leveraging their proprietary gene delivery platform, NAV Technology, to license their technology and collaborate with other pharmaceutical companies to advance gene therapy programs. They generate revenue through licensing agreements, milestone payments, and royalties from their partners, while retaining the rights to develop their own internal pipeline of therapies.
|
AGEN
$3.79
$0.3100
8.91%
Today's
|
|
|
AGEN
$3.79
$0.3100
8.91%
Agenus Inc
Agenus Inc stock improved 8.91% today.
Agenus Inc is a biotechnology company that primarily focuses on the discovery and development of immune-based therapies for cancer treatment. Their business model revolves around leveraging their proprietary technologies and capabilities to develop and commercialize therapeutic antibodies and vaccines. Agenus Inc also collaborates with other pharmaceutical companies through licensing agreements and partnerships to further advance their product pipeline.
|
TNYA
$0.488
$0.0384
8.54%
Today's
|
|
|
TNYA
$0.488
$0.0384
8.54%
Tenaya Therapeutics Inc
Tenaya Therapeutics Inc shares increased 8.54% today.
Tenaya Therapeutics Inc*s business model is centered around developing novel treatments for heart disease using regenerative medicine approaches, focusing on advanced therapies that repair and restore the heart*s function. They aim to bring these innovative therapies to patients by leveraging their expertise in drug discovery and development, and by collaborating with strategic partners in the healthcare industry.
|
BDTX
$2.11
$0.1600
8.21%
Today's
|
|
|
BDTX
$2.11
$0.1600
8.21%
Black Diamond Therapeutics Inc
Black Diamond Therapeutics Inc stock increased 8.21% today.
Black Diamond Therapeutics Inc*s business model is centered around developing targeted therapies for cancer patients by leveraging its proprietary platform and expertise in precision medicine.
|
XTNT
$0.715
$0.0526
7.94%
Today's
|
|
|
XTNT
$0.715
$0.0526
7.94%
Xtant Medical Holdings Inc
Xtant Medical Holdings Inc shares went up 7.94% today.
Xtant Medical Holdings Inc operates as a medical technology company that focuses on the development, production, and distribution of regenerative medical products and devices. It primarily offers orthopedic and spinal surgical implants and instruments, providing solutions to surgeons and patients for enhancing healing and improving patient outcomes.
|
ITOS
$8.41
$0.6000
7.68%
Today's
|
|
|
ITOS
$8.41
$0.6000
7.68%
Iteos Therapeutics Inc
Iteos Therapeutics Inc shares increased 7.68% today.
Iteos Therapeutics Inc is a company that focuses on developing innovative immunotherapies to treat cancer by targeting the tumor microenvironment.
|
LCTX
$0.4974
$0.0344
7.43%
Today's
|
|
|
LCTX
$0.4974
$0.0344
7.43%
Lineage Cell Therapeutics Inc
Lineage Cell Therapeutics Inc shares went up 7.43% today.
Lineage Cell Therapeutics Inc is a biotechnology company primarily focused on developing and commercializing novel cell therapies for degenerative diseases. They leverage their proprietary cell-based technology to create therapeutic products that target specific conditions like spinal cord injuries, age-related macular degeneration, and osteoarthritis. The company aims to provide innovative and effective treatments by utilizing their expertise in cellular biology and therapeutic research.
|
TARA
$3.42
$0.2300
7.21%
Today's
|
|
|
TARA
$3.42
$0.2300
7.21%
Protara Therapeutics Inc
Protara Therapeutics Inc stock went up 7.21% today.
Protara Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies to address significant unmet medical needs. Their business model revolves around identifying and advancing potential drug candidates that target specific diseases or conditions, conducting extensive research and development to ensure safety and efficacy, and ultimately seeking regulatory approvals and entering the market to make these therapies accessible to patients worldwide. Protara leverages collaborations and partnerships within the healthcare industry to support their research efforts and drive business growth.
|
ENZN
$0.0999
$0.0067
7.19%
Today's
|
|
|
ENZN
$0.0999
$0.0067
7.19%
Enzon Pharmaceuticals inc
Enzon Pharmaceuticals Inc shares went up 7.19% today.
Enzon Pharmaceuticals Inc. operates under a business model that focuses on the research, development, and commercialization of therapeutic drugs to address unmet medical needs. The company primarily employs a licensing strategy, partnering with other pharmaceutical companies to advance their drug candidates through clinical development and regulatory approval. By leveraging collaborations and out-licensing opportunities, Enzon aims to bring new therapies to market efficiently while maximizing shareholder value.
|
CADL
$5.7
$0.3500
6.54%
Today's
|
|
|
CADL
$5.7
$0.3500
6.54%
Candel Therapeutics Inc
Candel Therapeutics Inc stock improved 6.54% today.
Candel Therapeutics Inc*s business model is centered around developing and commercializing advanced biotherapeutics for the treatment of cancer. They aim to leverage their proprietary oncolytic viral immunotherapy technology to deliver targeted therapies that stimulate the patient*s immune system to attack and eliminate tumors. Through partnerships and collaborations, they seek to expand their reach and accelerate the development and delivery of innovative treatments.
|
MRNA
$26.39
$1.5300
6.15%
Today's
|
|
|
MRNA
$26.39
$1.5300
6.15%
Moderna Inc
Moderna Inc shares improved 6.15% today.
Moderna Inc*s business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases.
|
LENZ
$28.45
$1.6400
6.12%
Today's
|
|
|
LENZ
$28.45
$1.6400
6.12%
Lenz Therapeutics Inc
Lenz Therapeutics Inc shares improved 6.12% today.
|
SGMO
$0.4985
$0.0285
6.06%
Today's
|
|
|
SGMO
$0.4985
$0.0285
6.06%
Sangamo Therapeutics Inc
Sangamo Therapeutics Inc stock increased 6.06% today.
Sangamo Therapeutics Inc is a biotechnology company that focuses on developing genomic medicines. Their business model revolves around utilizing gene-editing technology to create therapies for genetic and rare diseases. They engage in research, development, and commercialization of their proprietary technologies to deliver innovative treatments with the potential to transform patients* lives.
|
KOD
$3.71
$0.2100
6.00%
Today's
|
|
|
KOD
$3.71
$0.2100
6.00%
Kodiak Sciences Inc
Kodiak Sciences Inc shares improved 6.00% today.
Kodiak Sciences Inc operates as a biopharmaceutical company that focuses on researching, developing, and commercializing innovative therapeutics to treat various retinal diseases. Their business model revolves around the discovery and development of novel drugs, while also conducting clinical trials and pursuing partnerships to bring these therapies to the market.
|
BNTX
$97.8
$5.0300
5.42%
Today's
|
|
|
BNTX
$97.8
$5.0300
5.42%
Biontech Se
Biontech Se stock improved 5.42% today.
Biontech SE*s business model focuses on the development and commercialization of novel mRNA-based immunotherapies for various diseases, including cancer.
|
ELUT
$1.81
$0.0900
5.23%
Today's
|
|
|
ELUT
$1.81
$0.0900
5.23%
Elutia Inc
Elutia Inc shares improved 5.23% today.
Elutia Inc operates as a technology company that specializes in the design and manufacturing of high-performance air purification systems. Their business model focuses on developing innovative and sustainable solutions to improve indoor air quality for various industries such as healthcare, education, hospitality, and more. By incorporating advanced technology and providing reliable products, Elutia aims to create a healthier and safer environment for their customers while also driving revenue through the sale and maintenance of their air purification systems.
|
ATYR
$3.44
$0.1700
5.20%
Today's
|
|
|
ATYR
$3.44
$0.1700
5.20%
Atyr Pharma Inc
Atyr Pharma Inc stock went up 5.20% today.
|
CHRS
$0.8
$0.0390
5.12%
Today's
|
|
|
CHRS
$0.8
$0.0390
5.12%
Coherus Biosciences inc
Coherus Biosciences Inc stock went up 5.12% today.
Coherus Biosciences Inc is a biopharmaceutical company focused on developing and commercializing high-quality biosimilar therapeutics. Their business model revolves around leveraging their expertise in cell culture, protein purification, formulation development, and analytical methods to manufacture and market biosimilar products. By providing cost-effective alternatives to expensive biologic drugs, Coherus Biosciences aims to make healthcare more accessible and affordable for patients.
|
ADAP
$0.2913
$0.0134
4.82%
Today's
|
|
|
ADAP
$0.2913
$0.0134
4.82%
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc stock improved 4.82% today.
Adaptimmune Therapeutics Plc is a biopharmaceutical company that focuses on developing and commercializing innovative cancer immunotherapy products. Their business model revolves around leveraging their T-cell receptor platform to engineer and develop targeted immunotherapies for patients with various types of cancer.
|
SLDB
$2.9
$0.1300
4.69%
Today's
|
|
|
SLDB
$2.9
$0.1300
4.69%
Solid Biosciences Inc
Solid Biosciences Inc stock improved 4.69% today.
Solid Biosciences Inc is a biotechnology company focused on developing gene therapies for individuals with Duchenne muscular dystrophy (DMD).
|
ADVM
$2.21
$0.0950
4.49%
Today's
|
|
|
ADVM
$2.21
$0.0950
4.49%
Adverum Biotechnologies Inc
Adverum Biotechnologies Inc shares increased 4.49% today.
Adverum Biotechnologies Inc*s business model is focused on developing gene therapies using its proprietary platform to deliver therapeutics for eye diseases.
|
REPL
$8.2
$0.3500
4.46%
Today's
|
|
|
REPL
$8.2
$0.3500
4.46%
Replimune Group Inc
Replimune Group Inc shares improved 4.46% today.
Replimune Group Inc has a business model centered around the development of oncolytic immunotherapies.
|
RLAY
$2.93
$0.1200
4.27%
Today's
|
|
|
RLAY
$2.93
$0.1200
4.27%
Relay Therapeutics Inc
Relay Therapeutics Inc shares went up 4.27% today.
Relay Therapeutics Inc is a biotechnology company focused on developing targeted therapies for diseases by leveraging insights from protein motion. Their business model involves utilizing computational simulations and algorithms to discover and design small molecule therapies that can effectively target specific proteins involved in various diseases.
|
Worst Performing Stocks From The Worst Performing (Legal Cannabis) Industry Today
MTEX
$9.01
$-1.5350
-14.56%
Today's
|
|
|
MTEX
$9.01
$-1.5350
-14.56%
Mannatech Incorporated shares dropped -14.56% today.
Mannatech Incorporated*s business model revolves around marketing and selling nutritional supplements and personal care products. The company primarily operates through a multi-level marketing (MLM) system, where independent associates are incentivized to recruit, sell products, and build their own network of distributors. Mannatech emphasizes the potential for financial success and personal development within the MLM structure.
|
SNYR
$2.113
$-0.2670
-11.22%
Today's
|
|
|
SNYR
$2.113
$-0.2670
-11.22%
Synergy Chc Corp shares declined -11.22% today.
Synergy Chc Corp operates on a direct-to-consumer business model, specializing in the development, distribution, and marketing of pharmaceutical and healthcare products. They deliver their products through various channels, including online platforms and retail stores. Their focus is on providing high-quality and affordable healthcare solutions to consumers worldwide.
|
RGC
$352.0158
$-40.9842
-10.43%
Today's
|
|
|
RGC
$352.0158
$-40.9842
-10.43%
Regencell Bioscience Holdings Limited stock declined -10.43% today.
Regencell Bioscience Holdings Limited operates under a business model that focuses on the development and commercialization of advanced biotechnology products. The company employs research and development to create innovative solutions in the field of cell therapy, regenerative medicine, and related technologies. Through strategic partnerships and collaborations, Regencell aims to bring its products to market to address various medical conditions and contribute to the growth of the biotech industry.
|
TLRY
$0.4531
$-0.0419
-8.46%
Today's
|
|
|
TLRY
$0.4531
$-0.0419
-8.46%
Tilray Brands Inc stock dropped -8.46% today.
Tilray Brands Inc operates as a cannabis-focused consumer packaged goods company. They develop and market a range of cannabis products, including dried flower, oils, capsules, and beverages, catering to medical and recreational users. With a focus on innovation and brand-building, Tilray Brands Inc aims to establish a strong presence in the cannabis industry and deliver high-quality products to its customers.
|
IMCC
$1.5441
$-0.1159
-6.98%
Today's
|
|
|
IMCC
$1.5441
$-0.1159
-6.98%
Im Cannabis Corp shares dropped -6.98% today.
Im Cannabis Corp operates as a vertically integrated cannabis company. They cultivate, manufacture, distribute, and sell medical cannabis and related products in Germany and Israel. Their business model focuses on combining production, distribution, and patient care to provide high-quality medical cannabis products to the growing market.
|
UPXI
$9.64
$-0.5500
-5.40%
Today's
|
|
|
UPXI
$9.64
$-0.5500
-5.40%
Upexi Inc shares went down -5.40% today.
Upexi Inc is a technology-driven company that operates on a platform-based business model. They provide a wide range of services through their platform, connecting customers with various service providers. Their revenue is generated through commissions or transaction fees earned from the services provided on their platform.
|
CHUC
$0.085
$-0.0040
-4.49%
Today's
|
|
|
CHUC
$0.085
$-0.0040
-4.49%
Charlie S Holdings Inc shares went down -4.49% today.
|
SNDL
$1.3
$-0.0500
-3.70%
Today's
|
|
|
SNDL
$1.3
$-0.0500
-3.70%
Sndl Inc shares declined -3.70% today.
Sndl Inc operates as a cannabis dispensary and retailer. The company sources and curates a wide variety of cannabis products and accessories for its customers. They generate revenue by selling these products through their physical stores and online channels.
|
CRON
$2.07
$-0.0700
-3.27%
Today's
|
|
|
CRON
$2.07
$-0.0700
-3.27%
Cronos Group Inc stock went down -3.27% today.
Cronos Group Inc operates as a vertically integrated cannabis company. Their business model revolves around cultivating, manufacturing, and distributing medical and recreational cannabis products. They aim to capture market share through their unique brands and partnerships with influential companies in various sectors.
|
ACB
$5.02
$-0.1100
-2.14%
Today's
|
|
|
ACB
$5.02
$-0.1100
-2.14%
Aurora Cannabis Inc shares declined -2.14% today.
Aurora Cannabis Inc operates as a vertically integrated cannabis company, controlling every aspect of the supply chain from cultivation to distribution. They focus on producing and selling medical and recreational cannabis products globally. This business model allows them to have greater control over product quality, streamline operations, and capitalize on the growing market for cannabis.
|
CGC
$1.64
$-0.0200
-1.20%
Today's
|
|
|
CGC
$1.64
$-0.0200
-1.20%
Canopy Growth Corporation shares dropped -1.20% today.
Canopy Growth Corporation*s business model revolves around being a leading producer and distributor of cannabis products, including both medicinal and recreational cannabis. The company focuses on cultivating, processing, and manufacturing various cannabis-based products, such as dried flowers, oils, and edibles. Canopy Growth Corporation also aims to expand its market presence through strategic partnerships and acquisitions, both domestically and internationally.
|
BTMD
$4.06
$-0.0400
-0.98%
Today's
|
|
|
BTMD
$4.06
$-0.0400
-0.98%
Biote Corp shares dropped -0.98% today.
Biote Corp*s business model focuses on the development and commercialization of biotechnology products or services.
|
USNA
$30.07
$-0.2000
-0.66%
Today's
|
|
|
USNA
$30.07
$-0.2000
-0.66%
Usana Health Sciences Inc shares went down -0.66% today.
Usana Health Sciences Inc is a multi-level marketing company that primarily sells nutritional supplements and personal care products. Through a network of independent distributors, the company focuses on direct selling and recruitment to generate sales and expand its customer base.
|
NAGE
$10.93
$-0.0200
-0.18%
Today's
|
|
|
NAGE
$10.93
$-0.0200
-0.18%
Niagen Bioscience Inc stock went down -0.18% today.
|
AMMJ
$0.0013
$0.0000
0.00%
Today's
|
|
|
AMMJ
$0.0013
$0.0000
0.00%
American Cannabis Company Inc shares dropped 0.00% today.
American Cannabis Company Inc is a cannabis consulting and solutions provider operating in the United States. They offer a range of services including cultivation facility design, equipment sourcing, branding, and operational support to help businesses in the cannabis industry succeed. Their business model revolves around providing expertise and resources to clients in order to help them navigate the complexities of the cannabis market and maximize their profitability.
|
NTRR
$0.0002
$0.0000
0.00%
Today's
|
|
|
NTRR
$0.0002
$0.0000
0.00%
Neutra Corp shares went down 0.00% today.
Neutra Corp is a company that focuses on the development and distribution of natural health products and supplements. Their business model centers around researching, producing, and marketing these products to cater to the growing demand for natural health and wellness solutions.
|
MDWD
$20.51
$0.0300
0.15%
Today's
|
|
|
MDWD
$20.51
$0.0300
0.15%
Mediwound Ltd shares improved 0.15% today.
Mediwound Ltd operates through the development, manufacturing, and commercialization of biopharmaceutical products. Their business model primarily involves leveraging their expertise in biotechnology to create innovative therapies for the treatment of severe burns, chronic wounds, and other healing disorders.
|
CYAN
$0.321
$0.0009
0.28%
Today's
|
|
|
CYAN
$0.321
$0.0009
0.28%
Cyanotech Corp stock improved 0.28% today.
Cyanotech Corp operates as a biotechnology company that specializes in the production of natural products derived from microalgae. The company cultivates and harvests microalgae, primarily spirulina and astaxanthin, which are used in various industries including dietary supplements, food and beverage, and cosmetics.
|
FTLF
$13.79
$0.1500
1.10%
Today's
|
|
|
FTLF
$13.79
$0.1500
1.10%
Fitlife Brands Inc shares improved 1.10% today.
Fitlife Brands Inc is a health and wellness company that operates through a business model focused on the development, marketing, and distribution of nutrition supplements and other related products. They create and promote their own branded supplements, as well as distribute products from other reputable brands. Their aim is to provide customers with high-quality and innovative products to support their fitness and well-being goals.
|
NAII
$3.31
$0.0600
1.85%
Today's
|
|
|
NAII
$3.31
$0.0600
1.85%
Natural Alternatives International Inc stock went up 1.85% today.
Natural Alternatives International Inc is a company that operates in the health and wellness industry. They specialize in developing and manufacturing science-based nutritional supplements and providing contract manufacturing services to clients across the globe.
|
AKAN
$1.225
$0.0250
2.08%
Today's
|
|
|
AKAN
$1.225
$0.0250
2.08%
Akanda Corp shares increased 2.08% today.
Akanda Corp is a technology company that employs a software-centric approach to network infrastructure for enterprises. Their business model focuses on providing open-source software solutions intended to simplify network operations and enhance network agility. By leveraging container-based virtualization technologies, they enable organizations to efficiently deploy and manage networks, ultimately optimizing performance and reducing costs.
|
MNMD
$7.01
$0.4100
6.21%
Today's
|
|
|
MNMD
$7.01
$0.4100
6.21%
Mind Medicine Mindmed Inc shares went up 6.21% today.
Mind Medicine (MindMed) is a biotech company that focuses on the development of psychedelic medicines to address mental health disorders. Their business model revolves around conducting clinical trials, obtaining regulatory approvals, and commercializing their psychedelic-based therapies. By leveraging scientific research and strategic partnerships, MindMed aims to provide innovative solutions for mental illness treatment and disrupt the traditional pharmaceutical industry.
|
FFNTF
$0.0029
$0.0005
20.83%
Today's
|
|
|
FFNTF
$0.0029
$0.0005
20.83%
4front Ventures Corp stock increased 20.83% today.
|
BON
$1.3
$1.2362
1,937.62%
Today's
|
|
|
BON
$1.3
$1.2362
1,937.62%
Bon Natural Life Limited stock increased 1,937.62% today.
Bon Natural Life Limited operates as a direct selling company that offers a range of natural and wellness products. They adopt a business model where independent distributors sell their products directly to customers, earning a commission from their sales.
|
|